Variables |
Hazard ratio (IC) |
p |
Hazard ratio (IC) |
p |
Age <50 ans |
0.84 (0.31-2.24) |
NS |
0.9 (0.34-2.4) |
NS |
Male gender |
2.2 (1.01-4.86) |
0.04 * |
1.95 (0.9-4.23) |
NS |
Cardiovascular risk factors |
|
|
|
|
Smoking |
2.63 (1.18-5.89 |
0.02* |
2.96 (1.34-6.55) |
0.007** |
Hypertension |
0.5 (0.11-2.16) |
NS |
0.38 (0.05-2.88) |
NS |
Diabetes |
0.88 (0.3-2.57) |
NS |
0.9 (0.25-3.24) |
NS |
Obesity |
1.27 (0.55-3) |
NS |
1.14 (0.51-3.80) |
NS |
Dyslipidemia |
0.88 (0.2-3.82) |
NS |
1.22(0.28-5.22) |
NS |
Previous venous thrombosis |
2.19 (1.01-4.76) |
0.04* |
4,11
(1.82-9.32) |
0.001** |
Previous cardiovascular events |
3.32 (1-11.2) |
0.04* |
4.23
(1.24-14.45) |
0.02* |
Family history of venous thrombosis |
1.19 (0.44-3.19) |
NS |
0.87 (0.33-2.3) |
NS |
Thrombosis circomstunces |
|
|
|
|
Idiopathic |
2,7 (1.03-7.36) |
0.04* |
2.24(0.82-6.07) |
NS |
Secondary to transient risk factor |
Referent |
|
Referent |
|
Persistant risk factor |
4.92 (1.64-14.74) |
0.004** |
2.57 (0.88-7.51) |
NS |
Localizations |
|
|
|
|
Proximal deep venous thrombosis |
0.95 (0.31-2.9) |
NS |
1.01
(0.32-3.14) |
NS |
|
1.93 (0.86-4.35)§
|
NS |
3.2 (1.36-7.54)
§
|
0.008** |
Pulmonary embolism |
0.19 (0.03-1,07) |
NS |
0.37(0.08-1.69) |
NS |
Distal deep venous thrombosis |
referent |
|
referent |
|
Treatment duration< 6 mois |
0.6 (0.14-2.74) |
NS |
0.28(0.06-1.24) |
NS |
Indefinite treatment duration |
0.97 (0.41-2.32) |
NS |
- |
- |
Post phlebitic syndrome |
2.68 (1.23-5.82) |
0,01* |
3.45
(1.59-7.48) |
0.002** |
Thrombophilia
|
1.45
(0.51-4.07)
|
0,49
|
1.31
(0.47-3.63)
|
0.6
|